Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 10

Evaluation of stroke risk factors and characteristics in the comorbidity of cancer

Pages
1887–1891
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As the time between stroke and cancer development decreases, while the risk factors for cancer are more prominent, classical risk factors for stroke are observed less frequently.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Stroke and cancer can be followed together and in the presence of cancer, there may be changes in classical stroke characteristics.
📊
Key Findings & Data:Materials and Methods: Patients who were hospitalized with the diagnosis of stroke between 2014-2020 were included in the study retrospectively.
💡
Conclusion & Impact:As the time between stroke and cancer development decreases, while the risk factors for cancer are more prominent, classical risk factors for stroke are observed less frequently.
🔬Design:Research Article
📍Scope:2014-2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Stroke and cancer can be followed together and in the presence of cancer, there may be changes in classical stroke characteristics. The aim of this study was to determine the effect of cancer on stroke risk factors, radiological and clinical features. Materials and Methods: Patients who were hospitalized with the diagnosis of stroke between 2014-2020 were included in the study retrospectively. By examining the stroke and cancer characteristics of the patients; The differences in demographic findings, stroke risk factors, and radiological features of stroke between patients with and without cancer were examined. The anti-cancer treatments used and the characteristics of cancer were evaluated in stroke patients. Results: 281 stroke patients were evaluated and cancer was detected in 52 patients. There was no significant difference in terms of demographic characteristics of the patients. No significant difference was observed in stroke patients with cancer in terms of risk factors except smoking and alcohol use. Multiple ischemic lesions were more evident on magnetic resonance imaging (MRI) in stroke patients with cancer. The most common cancer was lung cancer. Conclusion: Stroke and cancer are increasingly common comorbidities. As the time between stroke and cancer development decreases, while the risk factors for cancer are more prominent, classical risk factors for stroke are observed less frequently.

🔖

Cite This Article

Yilmaz, N. H., Duz, O. A., Polat, B., Aslan, A. S. (2022). Evaluation of stroke risk factors and characteristics in the comorbidity of cancer. Annals of Medical Research, Cilt: 28 - Sayı: 10, 1887–1891. https://ajindex.com/articles/445741

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wolf PA, D’Agostino RB, Belanger AJ, et al. Probability of stroke: a risk profile from the Framingham study. Stroke 1991;22:312-8
  2. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2008. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/ csr/ 1975_2008/. Accessed November 18, 2011 3. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/ 1975_2008/. Accessed November 18, 2011 4. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 1985;64:16-35
  3. Taccone FS, Jeangette SM, Blecic SA. First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis 2008;17:169-74
  4. Adams HP Jr, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53:126- 31
  5. Cestari DM, Weine DM, Panageas KS, et al. Stroke in patients with cancer: incidence and etiology. Neurology 2004;62:2025-30
  6. Levine SR. Hypercoagulable states and stroke: a selective review. CNS Spectrums 2005;10:567-578, Bick RL. Cancer-associated thrombosis. New Engl J Med 2003;349:109-11
  7. Sanossian N, Djabiras C, Mack WJ, Ovbiagele B. Trends in cancer diagnoses among inpatients hospitalized with stroke. J Stroke Cerebrovasc Dis 2013;22:1146- 50
  8. Kim SG, Hong JM, Kim HY, et al. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke 2010;41:798-801
  9. Chaturvedi S, Ansell J, Recht L. Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke 1994;25:1215-8
  10. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;4:2137 13. Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: a review. Acta Neurol Scand 2009;119:1-16
  11. Zhang Y, Cordato D, Shen Q, et al. Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study. Cerebrovasc Dis 2007;23:181-7
  12. Schwarzbach CJ, Schaefer A, Ebert A, Held V, Bolognese M, Kablau M, et al, Stroke and Cancer: The importance of Cancer-Associated Hypercoagulation as a Possible Stroke Aetiology. Stroke 2012;43:3029-34
  13. Lee EJ, Nah HW, Kwon JY,